W.E.P. Beyer

5.5k total citations · 1 hit paper
53 papers, 3.8k citations indexed

About

W.E.P. Beyer is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, W.E.P. Beyer has authored 53 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 18 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in W.E.P. Beyer's work include Influenza Virus Research Studies (45 papers), Respiratory viral infections research (20 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). W.E.P. Beyer is often cited by papers focused on Influenza Virus Research Studies (45 papers), Respiratory viral infections research (20 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). W.E.P. Beyer collaborates with scholars based in Netherlands, United Kingdom and United States. W.E.P. Beyer's co-authors include Albert D. M. E. Osterhaus, A.M. Palache, N. Masurel, Guus F. Rimmelzwaan, Ron A. M. Fouchier, J.C. de Jong, Vincent J. Munster, Chantal Baas, Martin Schutten and Pascal Lexmond and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

W.E.P. Beyer

52 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatial, Temporal, and Species Variation in Prevalence of Influenza A Viruses in Wild Migratory Birds

2007 568 citations Vincent J. Munster, Guus F. Rimmelzwaan et al. profile →

Peers

Countries citing papers authored by W.E.P. Beyer

Since Specialization

Citations

This map shows the geographic impact of W.E.P. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E.P. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E.P. Beyer more than expected).

Fields of papers citing papers by W.E.P. Beyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.E.P. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E.P. Beyer. The network helps show where W.E.P. Beyer may publish in the future.

Co-authorship network of co-authors of W.E.P. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of W.E.P. Beyer. A scholar is included among the top collaborators of W.E.P. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.E.P. Beyer. W.E.P. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines 2022 ·Vaccine ·W.E.P. Beyer, A.M. Palache, (unknown), Albert D. M. E. Osterhaus	3
2	Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine 2020 ·Vaccine ·W.E.P. Beyer, Albert D. M. E. Osterhaus	1
3	Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines 2019 ·Vaccine ·W.E.P. Beyer, A.M. Palache, Leslie A. Reperant, (unknown), Albert D. M. E. Osterhaus	8
4	Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis 2017 ·Vaccine ·Louise Lansbury, Sherie Smith, W.E.P. Beyer, (unknown), (unknown), (unknown), Ana Mateus, Hitoshi Oshitani, Hongxin Zhao, Charles Beck, Jonathan S. Nguyen‐Van‐Tam	43
5	Benefits of flu vaccination for persons with diabetes mellitus: A review 2017 ·Vaccine ·Marco Goeijenbier, Thomas T. van Sloten, Lennert Slobbe, Chantal Mathieu, Perry J.J. van Genderen, W.E.P. Beyer, Albert D. M. E. Osterhaus	80
6	The confounded effects of age and exposure history in response to influenza vaccination 2015 ·Vaccine ·(unknown), Janet E. McElhaney, Judith M. Fonville, Douglas C. Powers, W.E.P. Beyer, Derek J. Smith	80
7	Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza 2013 ·Vaccine ·W.E.P. Beyer, Janet E. McElhaney, Derek J. Smith, Arnold S. Monto, Jonathan S. Nguyen‐Van‐Tam, Albert D. M. E. Osterhaus	123
8	On the relationship between mean antibody level, seroprotection and clinical protection from influenza 2009 ·Biologicals ·(unknown), W.E.P. Beyer, Albert D. M. E. Osterhaus	50
9	The Molecular Basis of the Pathogenicity of the Dutch Highly Pathogenic Human Influenza A H7N7 Viruses 2007 ·The Journal of Infectious Diseases ·Vincent J. Munster, Emmie de Wit, Debby van Riel, W.E.P. Beyer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Thijs Kuiken, Ron A. M. Fouchier	115
10	Heterogeneity of case definitions used in vaccine effectiveness studies—And its impact on meta-analysis 2006 ·Vaccine ·W.E.P. Beyer	21
11	Bedenkingen tegen de richtlijn 'Influenzapreventie in verpleeghuizen en verzorgingshuizen' van de Nederlandse Vereniging van Verpleeghuisartsen 2005 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·J.C. de Jong, W.E.P. Beyer	1
12	Prevalence and Clinical Symptoms of Human Metapneumovirus Infection in Hospitalized Patients 2003 ·The Journal of Infectious Diseases ·Bernadette van den Hoogen, Gerard J. J. van Doornum, (unknown), Jan J. Cornelissen, W.E.P. Beyer, Ronald de Groot, Albert D. M. E. Osterhaus, Ron A. M. Fouchier	326
13	Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies 1996 ·European Journal of Clinical Microbiology & Infectious Diseases ·W.E.P. Beyer, A.M. Palache, René Kerstens, N. Masurel	72
14	Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents 1996 ·Vaccine ·A.M. Palache, W.E.P. Beyer, (unknown), Lisya Gerez, (unknown), Philip W. Ledger, (unknown), René Kerstens, (unknown), (unknown)	4
15	Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers 1993 ·Vaccine ·A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, (unknown), (unknown), B Charpentier, (unknown), (unknown), (unknown), Gerard J. Ligthart, G. Keren, Eitan Rubinstein	83
16	Impact of Influenza on Mortality in Relation to Age and Underlying Disease, 1967–1989 1993 ·International Journal of Epidemiology ·M Sprenger, Paul Mulder, W.E.P. Beyer, R. van Strik, N. Masurel	139
17	Effect of Immunomodulator Thymopentin on Impaired Seroresponse to Influenza Vaccine in Patients on Haemodialysis 1990 ·The Nephron journals/Nephron journals ·W.E.P. Beyer, (unknown), P. Kramer, (unknown), (unknown), Jeroen J. W. M. Janssen, N. Masurel, Willem Weimar	15
18	Antibody induction by influenza vaccines in the elderly: a review of the literature 1989 ·Vaccine ·W.E.P. Beyer, A.M. Palache, (unknown), N. Masurel	169
19	Intact Humoral Immune Response in Patients on Continuous Ambulatory Peritoneal Dialysis 1988 ·The Nephron journals/Nephron journals ·Dennis Versluis, W.E.P. Beyer, N. Masurel, (unknown), P. Kramer, Willem Weimar	17
20	Drift van het influenza A(H1N1)-virus; wijziging van het influenzavaccin voor het seizoen 1986/'87 1986 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·N. Masurel, W.E.P. Beyer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact